Literature DB >> 16378959

Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.

Rosario Sabariegos1, Mireia Giménez-Barcons, Natalia Tàpia, Bonaventura Clotet, Miguel Angel Martínez.   

Abstract

Short interfering RNAs (siRNAs) targeting viral or cellular genes can efficiently inhibit human immunodeficiency virus type 1 (HIV-1) replication. Nevertheless, the emergence of mutations in the gene being targeted could lead to the rapid escape from the siRNA. Here, we simulate viral escape by systematically introducing single-nucleotide substitutions in all 19 HIV-1 residues targeted by an effective siRNA. We found that all mutant viruses that were tested replicated better in the presence of the siRNA than in the presence of the wild-type virus. The antiviral activity of the siRNA was completely abolished by single substitutions in 10 (positions 4 to 11, 14, and 15) out of 16 positions tested (substitution at 3 of the 19 positions explored rendered nonviable viruses). With the exception of the substitution observed at position 12, substitutions at either the 5' end or the 3' end (positions 1 to 3, 16, and 18) were better tolerated by the RNA interference machinery and only in part affected siRNA inhibition. Our results show that optimal HIV-1 gene silencing by siRNA requires a complete homology within most of the target sequence and that substitutions at only a few positions at the 5' and 3' ends are partially tolerated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16378959      PMCID: PMC1346856          DOI: 10.1128/JVI.80.2.571-577.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Argonaute2, a link between genetic and biochemical analyses of RNAi.

Authors:  S M Hammond; S Boettcher; A A Caudy; R Kobayashi; G J Hannon
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

2.  Kinetic analysis of the RNAi enzyme complex.

Authors:  Benjamin Haley; Phillip D Zamore
Journal:  Nat Struct Mol Biol       Date:  2004-05-30       Impact factor: 15.369

3.  Picking a winner: new mechanistic insights into the design of effective siRNAs.

Authors:  Delquin Gong; James E Ferrell
Journal:  Trends Biotechnol       Date:  2004-09       Impact factor: 19.536

Review 4.  Therapeutic potential of RNA interference.

Authors:  Mario Stevenson
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

5.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

6.  Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays.

Authors:  A G Rodrigo; P C Goracke; K Rowhanian; J I Mullins
Journal:  AIDS Res Hum Retroviruses       Date:  1997-06-10       Impact factor: 2.205

7.  Genetic variation in AIDS viruses.

Authors:  J M Coffin
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

8.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

9.  Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay.

Authors:  C A Boucher; W Keulen; T van Bommel; M Nijhuis; D de Jong; M D de Jong; P Schipper; N K Back
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

10.  RISC is a 5' phosphomonoester-producing RNA endonuclease.

Authors:  Javier Martinez; Thomas Tuschl
Journal:  Genes Dev       Date:  2004-04-22       Impact factor: 11.361

View more
  34 in total

1.  RNA interference against animal viruses: how morbilliviruses generate extended diversity to escape small interfering RNA control.

Authors:  Carine L Holz; Emmanuel Albina; Cécile Minet; Renaud Lancelot; Olivier Kwiatek; Geneviève Libeau; Renata Servan de Almeida
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  HIV-l and the microRNA-guided silencing pathway: an intricate and multifaceted encounter.

Authors:  Patrick Provost; Corinne Barat; Isabelle Plante; Michel J Tremblay
Journal:  Virus Res       Date:  2006-08-04       Impact factor: 3.303

Review 3.  RNA interference and antiviral therapy.

Authors:  Yan Ma; Chu-Yan Chan; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

Review 4.  Emergence of a complex relationship between HIV-1 and the microRNA pathway.

Authors:  Dominique L Ouellet; Isabelle Plante; Corinne Barat; Michel J Tremblay; Patrick Provost
Journal:  Methods Mol Biol       Date:  2009

5.  Induction of interleukins IL-6 and IL-8 by siRNA.

Authors:  E Pauls; J Senserrich; M Bofill; B Clotet; J A Esté
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 6.  Engineering T Cells to Functionally Cure HIV-1 Infection.

Authors:  Rachel S Leibman; James L Riley
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

7.  Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect.

Authors:  Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 8.  RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

Authors:  Sandesh Subramanya; Sang-Soo Kim; N Manjunath; Premlata Shankar
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

9.  Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs.

Authors:  Nick C T Schopman; Olivier ter Brake; Ben Berkhout
Journal:  Retrovirology       Date:  2010-06-08       Impact factor: 4.602

10.  Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference.

Authors:  Karin Jasmijn von Eije; Olivier ter Brake; Ben Berkhout
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.